| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 销售药品收入(元) | 207,010,862.35 | 323,027,954.21 | 159,164,869.95 | 299,174,384.77 | 145,205,397.14 |
| 医疗服务收入(元) | 615,059,978.23 | 1,091,016,583.74 | 539,074,157.77 | 1,005,785,575.36 | 491,244,291.79 |
| 供应链业务(元) | 1,987,320.72 | 4,748,829.38 | 2,697,024.64 | - | - |
| 营业成本(元) | |||||
| 销售药品收入(元) | 177,203,261.55 | 287,622,610.43 | 140,384,913.44 | 276,910,514.61 | 133,589,180.54 |
| 医疗服务收入(元) | 429,548,417.89 | 795,502,994.83 | 381,758,233.59 | 735,220,381.22 | 353,065,208.13 |
| 供应链业务(元) | 1,855,712.19 | 4,498,120.89 | 2,498,927.18 | - | - |
| 毛利(元) | |||||
| 销售药品收入(元) | 29,807,600.80 | 35,405,343.78 | 18,779,956.51 | 22,263,870.16 | 11,616,216.60 |
| 医疗服务收入(元) | 185,511,560.34 | 295,513,588.91 | 157,315,924.18 | 270,565,194.14 | 138,179,083.66 |
| 供应链业务(元) | 131,608.53 | 250,708.49 | 198,097.46 | - | - |
| 毛利率(%) | |||||
| 销售药品收入(%) | 14.40 | 10.96 | 11.80 | 7.44 | 8.00 |
| 医疗服务收入(%) | 30.16 | 27.09 | 29.18 | 26.90 | 28.13 |
| 供应链业务(%) | 6.62 | 5.28 | 7.35 | - | - |
| 收入构成(%) | |||||
| 销售药品收入(%) | 25.12 | 22.77 | 22.71 | 22.93 | 22.81 |
| 医疗服务收入(%) | 74.64 | 76.90 | 76.91 | 77.07 | 77.19 |
| 供应链业务(%) | 0.24 | 0.33 | 0.38 | - | - |
| 毛利构成(%) | |||||
| 销售药品收入(%) | 13.83 | 10.69 | 10.65 | 7.60 | 7.75 |
| 医疗服务收入(%) | 86.10 | 89.23 | 89.23 | 92.40 | 92.25 |
| 供应链业务(%) | 0.06 | 0.08 | 0.11 | - | - |